Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder	Recruiting	Not applicable	2026-02-27		NCT06539624

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The Children's Hospital of Zhejiang University School of Medicine	74

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital, Zhejiang University School of Medicine	Hangzhou	China	8
Shanghai Children's Medical Center	Shanghai	China	4